Biomarin Pharmaceutical – Welcome to stockcalc’s blog archive. We’ve launched a new blog! Visit us here.

Bio-Techne (TECH:NAS) Fundamental Valuation Report

By admin Posted on September 3, 2020 Posted in Fundamental Valuation Report

Fundamental Valuation Report Bio-Techne(TECH:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$261.57 (USD) 09/02/2020 Weighted Valuation$277.40 (USD) Overall RatingUndervalued by 6.1% Valuation Models Comparables: $240.00 (USD) Multiples: $224.38 (USD) Valuation …

Bio-Techne (TECH:NAS) Fundamental Valuation Report Read more »

Tesla (TSLA:NAS) and Biomarin Pharmaceutical (BMRN:NAS) Downgraded

By Brian Donovan Posted on December 18, 2018 Posted in Downgraded Stocks

Stockcalc – Free Trial Have a free look inside the StockCalc website at www.stockcalc.com I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available …

Tesla (TSLA:NAS) and Biomarin Pharmaceutical (BMRN:NAS) Downgraded Read more »

Tag: Biomarin Pharmaceutical

Bio-Techne (TECH:NAS) Fundamental Valuation Report

Tesla (TSLA:NAS) and Biomarin Pharmaceutical (BMRN:NAS) Downgraded

Anheuser-Busch InBev (BUD:NYS) and T. Rowe Price Group (TROW:NAS) Upgraded

Cardinal Health (CAH:NYS) and Boston Properties (BXP:NYS) Upgraded

Priceline Group (PCLN:NAS) and Qualcomm (QCOM:NAS) Downgraded